Percutaneous absorption of testosterone from the ventral forearm in newborn rhesus monkeys was determined as a mcasure of skin barrier function. Skin absorption at a concentration of 4 and 40 pg/cm2 were, respectively, 22.5 r 2.2% (SD) and 6.8 r 2.1% of the applied dose, values which were not significantly different ( P > 0.05) from those of adult rhesus and which were similar to man. If the absorption is expressed as micrograms absorbed systemically, then the amounts are 0.9 and 2.7 pg/cm2 area of skin, a 3-fold increase in systemic absorption per 10-fold increase in topical dose. Occlusion of a dose of 4 0 pg/ cm2 enhanced absorption to 14.7%.
CONCLUSION
Percutaneous absorption of testosterone from the ventral forearm in newborn rhesus monkeys was determined as a mcasure of skin barrier function. Skin absorption at a concentration of 4 and 40 pg/cm2 were, respectively, 22.5 r 2.2% (SD) and 6.8 r 2.1% of the applied dose, values which were not significantly different ( P > 0.05) from those of adult rhesus and which were similar to man. If the absorption is expressed as micrograms absorbed systemically, then the amounts are 0.9 and 2.7 pg/cm2 area of skin, a 3-fold increase in systemic absorption per 10-fold increase in topical dose. Occlusion of a dose of 4 0 pg/ cm2 enhanced absorption to 14.7%.
The ratio of surface area (square centimeters) to body weight (kilograms) in the newborn is 3 times that in the adult. Therefore, given equal application area of skin per newborn and adult, the systemic availability in the newborn also becomes 3-fold when based on kilograms of body weight. With a different ratio of skin surface to body weight, the therapeutic ratio probably is lower in the newborn than in the adult when the compound is applied topically. This difference between newborn and adult in systemic availability after topical application may help explain some of the toxicity reported in newborns.
Summary
The mean 2 SEM of the cord, 48-hr, and 7-day values for serum calcium, magnesium, liuman calcitonin (IICT), parathyroid hormone (PTH), and 25-hydroxy-vitamin D (25-OHD) for preniature and term infants can be seen in Table 1 .
Mean cord calcium concentrations were similar for term and premature infants. Serum calcium concentrations fell in both tern1 and premature infants at 4 8 hr, but decreased more in the premature infants (froni 10.23 & 0.30 to 8.74 2 0.19 mg/dl) than in the term infants (froni 10.5 + 0.26 to 9.6 2 0.23 mgldl).
Serum calcium values increased from 4 8 hr to 7 days in both groups, and there was no significant difference between term and preniature infants' seruni calcium concentrations (10.6 2 0.28 and 10.12 + 0.3 mg/dl, respectively) at that time. There was no significant difference between ter~ii and premature cord serum magnesium concentrations. Seru~ii magnesium concentrations increased siniilarly by 4 8 hr in both groups and reniained at these concentrations at 7 days of life. Serum H C T concentrations were elevated above normal adult levels (71.9 2 6.6 pglml, 81% < 100 pglml, n = 63) in both premature and term cord sera, but premature cord concentrations (146 + 24 pglml) were significantly higher than term cord concentration (91 + 2 1 pgl ml). Both term and premature infants displayed a 2-3-fold increase in serum H C T by 4 8 hr and a partial fall by 7 days to concentrations still above those seen in cord sera (Fig. 1) . Nine of 1 0 premature and 9 of 1 0 term infants had undetectable PTII concentrations in cord sera. In two premature infants, PTH serum concentration remained undetectable at 4 8 hr. Iiowever, the majority of both premature and term infants had elevated levels of PTH a t 4 8 hr. The mean PTH concentrations were lower but still elevated at 7 days with the suggestion of higher concentrations in premature infants (Fig. 2 ). There were no significant differences in serum 25-OHD concentrations between term and premature sera at birth or at 7 days.
There was a weakly positive correlation between 25-OIiD and cord calcium ( r = 0.45, P < 0.05), and a negative correlation between cord calcium and 48-hr PTH ( r = -0.53, P < 0.01).
Calcium and magnesium were significantly positively correlated in 48-hr ( r = 0.83) and 7-day ( r = 0.84) sera in premature infants but not in term infants. Cord 25-OHD and cord IICT levels were significantly positively correlated ( r = 0.80, P < 0.01) in the term infants but not the premature infants.
Speculation
IICT may play a significant role in perinatal mineralization of bone and the high levels seen in premature infants may contribute to early neonatal hypocalcemia. Lack of PTII compensatory response in a subgroup of premature infants and magnesium def;rciency in selected pkniat;re infants lnay further c o~n~r o n~i s e calcium homeostasis. Evidence for a primary role of 25-OI1D deficiency in early neonatal hypocalcemia was not found. The role of vitamin D in placental calcium transport and the interaction of vitamin D and HCT in perinatal bone turnover require further study.
The majority of premature infants experience a brief period of decreased serum calcium at 24-48 hr of life. When the decrease is significant, the diagnosis of early neonatal hypocalcemia is made (43) . The pathogenesis of this fall in serum calcium has not been clearly defined; however, inadequate PTH secretion (7, 39) and increased serum HCT concentrations (8, 11) have been implicated. Magnesium deficiency may also cause decreased PTH secretion and/or end organ response (1, 4) . PTH increases gastrointestinal calcium absorption by increasing conversion of 25-OHD to 1,25-dihydroxyvitamin D (1,25-(OH),D) (10, 12) which increases calcium transport across the gastrointestinal mucosa (26) . The efficacy of PTH in the resorp tion of bone is facilitated by adequate vitamin D (26) . Conceivably, effective vitamin D deficiency could be a factor contributing to significant decreases in serum calcium in the early neonatal period. Rosen et al. (34) We have therefore analyzed serial sera (cord, 48-hr and 7-day) from premature and term infants for calcium, magnesium, HCT, PTH, and 25-OHD in order to gain a more comprehensive view of neonatal calcium homeostasis.
METHODS

PATIENTS
Eleven premature and 10 term infants were studied during their initial hospitalization in St. Louis in February 1976. All sequentially born, healthy premature infants were studied. The premature infants weighed 1500-2000 g and were born after 31-36 weeks of gestation. They were healthy prematurcs who were able to begin oral feedings of a standard formula within the first 24 hr of life, and only one required limited oxygen therapy. Except for ampicillin and kanamycin, they received no additional drugs or vitamin supplements. The term infants were randomly selected infants delivered by cesarian section for various reasons but had no neonatal problems requiring more than the routine observation for 6 hr. Informed consent was obtained from parents of all infants.
BLOOD SAMPLES
Cord blood was centrifuged and the serum frozen within 3 hr; 2.5 ml blood were obtained by heel stick at 4 8 hr and at 7 days of age, and the blood was allowed to clot at room temperature. It was then centrifuged and the serum frozen. All sera were stored frozen until samples from all 21 babies had been obtained. ASSAYS 25-OHD was measured by the competitive protein binding radioassay of Haddad and Chyu (15) . Calcium and magnesium were measured on a flame atomic absorption spectrometer as described previously (13, 29) . PTH was measured by a radioimmunoassay, which uses a rooster antiserum to bovine PTH that recognizes intact hormone (1-84) and carboxyterminal fragments (21) . HCT was measured by a sensitive HCT radioimmunoassay which uses a guinea pig antiserum that recognized intact HCT and its carboxyternlinal fragments (32) . Because of the limited volunle of sera, 25-OHD concentrations were not performed on 48-hr samples. Cord and 7-day 25-OHD sanlples were assayed in two separate assays. All of the sequential PTH and HCT measurements were made in single assays to avoid interassay variation. All serum calcium and magnesium determinations were analyzed on the same day.
RESULTS
The mean + SEM of the cord, 48-hr, and 7-day values for serum calcium, magcnsium, HCT, PTH, and 25-OHD for premature and term infants can be seen in Table 1 .
CALCIUM
Mean cord calcium concentrations were similar for tern1 and premature infants at 4 8 hr, but decreased more in the prematures (from 10.23 + 0.30 to 8.74 + 0.19 mg/dl) than in the term infants (from 10.5 + 0.26 to 9.6 + 0.23 mg/dl). Serum calcium values increased from 48 hr to 7 days, at which time there was no significant difference between term and premature infants' serum calcium concentrations (10.6 + 0.28 and 10.12 a 0.3 mg/ dl, respectively).
MAGNESIUM
There was no significant difference between term and premature cord serum magnesium concentrations. Serum magnesium concentrations increased similarly by 4 8 hr in both groups and remained at these concentrations at 7 days of life.
HCT H C T serum concentrations were elevated above normal adult levels (71.9 +-6.6 pg/ml, 81% < l o 0 pglml, n = 63), in both premature and term cord sera, but premature cord concentrations (146 ' . 24 pg/ml) were significantly higher than term cord concentration (91 + 21 pg/ml). Both term and premature infants displayed a 2-3-fold increase in serum HCT by 48 hr and a partial fall by 7 days to concentrations which were still above those seen in cord sera (Fig. 1) . Cord, 48-hr, and 7-day serum parathyroid hormone in term infants (left) and premature infants (right). *: >20; **: >>20. Normal parathyroid hormone range: 2-10 p1 Eq/ml.
'L"L
Nine of 10 premature and 9 of 1 0 term infants had undetectable PTH concentrations in cord sera. In two premature infants, serum PTH concentration remained undetectable at 48 hr. However, the majority of both premature and term infants had elevated levels of PTH at 4 8 hr. The mean PTH concentrations were lower but still elevated at 7 days with slightly higher concentrations in premature infants (Fig. 2 ).
There were no significant differences in serum 25-OHD concentrations between term and premature sera at birth or at 7 days.
CORRELATIONS
There was a weak positive correlation between 25-OHD and cord calcium ( r = 0.45, P < 0.05), and a negative correlation between cord calcium and 48-hr PTH ( r = -0.53, P < 0.01).
Calcium and magnesium were significantly positively correlated in 48-hr ( r = 0.83) and 7-day ( r = 0.84) sera in premature infants but not in tern1 infants. Cord 25-OHD and cord HCT concentrations were significantly positively correlated ( r = 0.80), P < 0.01) in the term infants but not the premature infants. No significant correlations were found among the other parameters analyzed, including HCT and PTH ratios and cord 48-hr calcium differences. Individual data from the four prematures with the lowest 48-hr serum calcium concentrations (< 8.5 mgldl) can be seen in Table 2 .
DISCUSSION
This study was designed to examine serially some of the factors important to early neonatal extracellular calcium homeostasis, since such a study does not exist in the literature. Although all of these factors are relevant to early neonatal hypocalcemia, the study was done in a prospective fashion so that 48-hr serum calcium values were unknown. The premature population studied was not the population with the highest incidence of early hypocalcemia; i.e., sick infants, NPO, <32 weeks of gestation. Nevertheless, there was a significant difference between the mean 48-hr calcium value in premature infants (8.7 + 0.19 mg/dl) and term infants (9.6 & 0.23 mg/dl) ( P < 0.005). The premature infants had significantly higher cord HCT concentrations in spite of the similar calcium concentrations in term and premature cord sera. Cord HCT concentrations were not correlated with cord total calcium in this study, and there was also no correlation with cord-ionized calcium in 10 saniples previously studied by us (32) . All but one term infant showed a further marked increase in HCT by 48 hr. Others have shown that the peak in serum HCT is at about 24 hr (8, 11) . Serum glucagon and epinephrine, which are nlarkedly increased shortly after birth, niay stimulate HCT release (33) and be in part responsible for the HCT increase seen in all of the infants studied. In a very large series, Dirksen and Anast (11) have shown increased serum HCT concentrations in infants who have significant hypocalceniia during the first 4 8 hr of life. Seruni HCT remained significantly elevated above cord concentrations in both groups at 7 days and HCT conccntrations in the premature infants remained slightly higher ( P < 0.1) than those of the term infants. HCT nlay play a significant role in pronioting irl rciero and postnatal bone n~ineralization, and possibly promoting placental transport of calcium. HCT blocks bone resorption, especially in young animals with rapid bone turnover. In rats, young age and a diet high in phosphate predispose to a greater hypocalcemia response to HCT injection (35) . However, HCT has had limited usefulness in treating hypercalcemia of adults, and adult patients with medullary cancer of the thyroid and very high serum HCT d o not have hypocalcemia or increased serum PTH (9) . Increased HCT concentrations also are associated with decreased receptor sites for HCT in bone (46) . Although there is not much precedent for HCT causing hypocalcenlia in adult humans, this possibility exists in the hunian newborn infant.
There were no significant differences between the seruni PTH concentrations of term and prenlature infants. Eighteen of 20 cord serum PTH concentrations were undetectable (<7 pI Eq/ nil), and it has been postulated that this represents a functional suppression secondary to the high fetal serum ionized calciun~ concentrations, which are maintained by active transport of calciunl across the placenta (40) . The one infant with an elevated cord PTH concentration (15 p1 Eqlml) had the lowest cord calcium (8.8 nig/dl). By 48 hr, most of the infants had elevated PTH levels which exhibited a significantly negative correlation with cord calcium ( r = 0.53, P < 0.01). Tsang ei 01. (40) have shown a similar negative correlation in infants of diabetic mothers between cord ionized calcium and PTH serum concentrations using an N-terminal radioimmunoassay; however, they did not show this correlation in normal infants. Whereas the term infants presented a homogeneous intern~ediate PTH rcsponse, the premature infants fell into two groups, six infants with high PTH levels at 48 hr and at 7 days, and five infants with undetectable or normal levels at 48 hr and at 7 days (Fig. 2) . Although a correlation between serum PTH concentration and 48-hr seruni calciunl concentrations could not be made, three of the four infants with the lowest 48-hr scruni calciunl values (calcium < 8.5 nig/dl) were from this group of five infants with the lower PTH responses.
Tsang et al. (39) , using an N-terminal radioimmunoassay, have found lower PTH levels in the majority of the premature infants they have studied. Also, Tsang ei nl. (39) showed a decrease in the magnitude of PTH response to the hypocalcemia of exchange transfusion with decreasing gestation as well as before 52 hr of age compared to after 52 hr of age. David and Anast (7), using the same C-terminal antisera used in our assay, have shown elevated PTH serum concentrations in normal and especially "sick," but not hypocalccmic infants. In other studies with a different antisera, David et 01. (8) report consistently high levels of PTH in premature infants. The variation in data from different investigators probably results from the use of different antisera and reviews of these differences have been published (2, 33) . N-terminal assays may be best to measure acute secretion, but may underdetect chronic conditions. Carboxyterminal assays diagnose chronic conditions, but may overestiniate serum PTH conccntrations because of their recognition of inactive, carboxyterminal fragments in the circulation. If renal degradation of PTH fragments is impaired in the prenlature infant, this could cause a serious overestiniation of PTH secretion.
In recent studies of late neonatal hypocalcenlia tetany, a high incidence of hypomagnesemia has been preorted (5, 6 ). Tsang and Oh (42) reportcd niagnesium deficiency in small for gestational age infants and have recently reported transient hyponiagneseniia in a high percentage of infants of diabetic niothcrs (44) . The general prevalance of maternal hypomagnesemia is just coming under study (3) . In this study, seruni nlagnesiunl concentrations were similar and followed identical courses in tern1 and appropriate for gestational age (AGA) prenlature infants as previously seen in a larger series (42) . The significant positive correlation between serum niagensium and serum calciun~ at both 48 hr and 7 days seen in preniature infants, but not term infants, raises the possibility of a direct relationship between magnesium and calciun~ honicostasis in A G A preniatures. Qucstions remain about the ability of PTH target tissues in prenlature infants to respond to PTH and vitamin D. In tern1 infants, urinary cyclic AMP and urinary phosphate excretion increase in a parallel fashion to PTH increase in the first 3 days of life (23) and exogenous PTH can produce an increase in cyclic urinary AMP and phosphate excretion (23) . However, in hypocalcemic premature infants, no cyclic AMP rcsponse was seen to exogenous PTH (22) . Tsang ei nl. (41) demonstrated an increased serum calciun~ in premature infants in rcsponse to exogenous PTH; however, the mechanism of that increase is unknown. PTH acts to increase the conversion of 25-OHD to 1,25-(OH),D, the active form of vitamin D , which increases calcium transport in the gastrointestinal tract (10, 25) . 1,25-(OH),D niay also be important in the PTH-initiated n~obilization of calciuni from bone (26) . This 1-hydroxylation of 25-OHD occurs in the kidney tubules, and it is not known whether the ininiature human kidney can carry out this conversion. Since large amounts of sera are necessary to measure 1,25-(OH),D, 1,25-(OH),D serum conccntrations have not bcen studied in prenlature infants. Since serum 25-OHD concentrations often fall in premature infants ( l 7 ) , suggesting decreased 25-hydroxylation in the liver (24) , a period of dccreascd 25-OHD l-hydroxylation by the kidney would not be surprising.
Because maternal serum 25-OHD conccntrations dcterniine infant serum 25-OHD concentrations, we have previously studied the factors contributing to low maternal serum 25-OHD concentration in St. Louis (18) . The predominant factor was season at time of sampling. During winter vitamin D intake was weakly correlated with 25-OHD serum concentrations. The hypocalcemia infants in the study of Rosen et al. (34) were also winterborn and those whose mothers had low vitamin D intakes had low 25-OHD levels, whereas those whose mothers had good vitamin D intakes had normal levels. The population in this study was a mixture of socioeconomic classes with varying prenatal care and vitamin intakes during pregnancy but all born within the month of February. This was predicted to give a significant range of serum 25-OHD concentrations with many low values. This indeed occurred for both the term infants (14.2 ? 2.5,4-26 nglml) and premature infants (1 1.27 2 1.9, 6-20 nglml) . The data presented provides no support for a role of 25-OHD deficiency in early neonatal hypocalcemia. Although the premature infants studied had significantly lower serum calcium concentrations at 4 8 hr than the full term infants, their 25-OHD levels were not different from those of the term infants at either birth or at 7 days. Further, there was no correlation between low 25-O H D levels and low 48-hr serum calcium concentrations in either the term or premature infants. A correlation between normal serum 25-OHD and calcium has not usually been found (18, 3 6 ) . Gupta et al. (14) , however, found a correlation between 25-OHD serum concentrations and serum calcium in a group of D-deficient Asians having a mean serum 25-OHD concentration of 9.9 ng/ml in April and 14.7 ng/ml in October and mean calcium concentration of 8.9 mg/dl in April and 9.25 mg/dl in October. We have found very late hypocalcemia (19, 20) in 11 premature infants with very low 25-OHD levels. Severe osteopenia, often progressing to frank rickets, was seen in these infants. Similarly, in adult Asians in Britain who were chronically vitamin D deficient, hypocalcemia and increased alkaline phosphatase were seen at 25-OHD levels of 2.2 2 0.9 ng/ml and rickets at concentrations < 0.8 ng/ml (27) .
In the present series, sampled in winter to give a low range of 25-OHD concentrations, there was a weak correlation (r = 0.45, P < 0.05) between cord 25-OHD and cord calcium but not magnesium. Roginsky et al. (31) , in a series of 37 cord blood samples, did not find such a correlation. More studies are needed to see whether vitamin D plays any role in placental calcium transport similar to its role in gastrointestinal calcium transport. There was also a positive correlation ( r = 0.80, P < 0.01) between cord 25-OHD and cord HCT in the 10 term infants but no correlation (r = -0.54, P not significant) in the 11 premature infants. A direct relationship between 25-OHD concentrations and PTH was not suggested by this study.
The incidence of late neonatal hypocalcemia is so low that the lack of correlation between 25-OHD and 7-day calcium in this small series does not rule out a role for 25-OHD deficiency in late neonatal hypocalcemia. The epidemiological data for such an association is quite good (28, 30, 45) , and a larger prospective study is in progress.
CONCLUSION
Serial determinations of serum calcium, magnesium, calcitonin, PTH, and 25-OHD in a series of premature and term infants indicate lower 48-hr serum calcium concentrations and higher scrum HCT concentrations in premature infants. Hypocalccmia may bc further provoked by lack of a PTH compcnsatory responsc in a subgroup of premature infants, and magnesium deficiency in sclected infants. Evidence for a primary role of 25-OHD deficiency in early neonatal hypocalcemia was not found; however, 25-OHD la-hydroxylase activity was not appraised.
